Timothy Lee
Neurology · Nashville, TNNPI 1790736650
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 10.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,269 and has fallen 81.5% since, to $235 in 2022. That places this record below the midpoint for neurology clinicians in TN, where the typical reported total is $2,246.
Across 139 payments — averaging $15.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$227
- Amgen$190
- Novartis$178
- Acadia Pharmaceuticals Inc$166
- Sunovion Pharmaceuticals Inc.$164
- UCB, Inc.$125
- plus $1K from 31 others
What the payments were for
- Food & beverage$2,159100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 16 | $227 |
| Amgen | 11 | $190 |
| Novartis | 10 | $178 |
| Acadia Pharmaceuticals Inc | 10 | $166 |
| Sunovion Pharmaceuticals Inc. | 19 | $164 |
| UCB, Inc. | 7 | $125 |
| Supernus Pharmaceuticals, Inc. | 10 | $115 |
| Sanofi | 5 | $104 |
| Biohaven Pharmaceuticals, Inc. | 4 | $78 |
| Biogen | 4 | $74 |
| Teva Pharmaceuticals USA, Inc. | 4 | $73 |
| AstraZeneca(2 entities) | 4 | $55 |
| Eisai Inc. | 3 | $49 |
| Theratechnologies Inc. | 3 | $48 |
| Nestle Healthcare Nutrition Inc. | 2 | $44 |
| Novo Nordisk | 2 | $38 |
| EMD Serono, Inc. | 2 | $37 |
| Medtronic | 2 | $34 |
| Esperion Therapeutics, Inc. | 2 | $27 |
| Assertio Therapeutics, Inc. | 2 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| Akcea Therapeutics, Inc. | 1 | $23 |
| GSK | 1 | $22 |
| Genentech USA, Inc. | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
| Insulet Corporation | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| CSL Behring | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Upsher-smith Laboratories LLC | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Bausch Health US, LLC | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
| Lundbeck LLC | 1 | $12 |
How this compares
$2,159 in reported general payments places this provider in the 45th percentile of 361 neurology providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 12 | $86 |
Paid to pharmacies, not to this prescriber.
Other neurology in Nashville
- Harold MosesNashville$438K
- Daniel ClaassenNashville$285K
- Francesca BagnatoNashville$167K
- Philip CharlesNashville$132K
- Benjamin HoffmanNashville$124K
- Joy DerwenskusNashville$107K
- James EatonNashville$85K
- Elizabeth FerlugaNashville$77K
- Britt StoneNashville$75K
- Lavanya NagineniNashville$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.